RT Journal Article SR Electronic T1 DIFFERENTIAL EXPRESSION OF CB1 CANNABINOID RECEPTOR AND CANNABINOID RECEPTOR INTERACTING PROTEIN 1A IN LABOR JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.12.06.20244749 DO 10.1101/2020.12.06.20244749 A1 Melissa L. Kozakiewicz A1 Jie Zhang A1 Sandra Leone-Kabler A1 Liliya M. Yamaleyeva A1 Brian C. Brost A1 Allyn C. Howlett YR 2020 UL http://medrxiv.org/content/early/2020/12/07/2020.12.06.20244749.abstract AB Background The endocannabinoid system is present in multiple organ systems and is involved in smooth muscle regulation, immune function, neuroendocrine modulation and metabolism of tissues. Limited data are available regarding the presence and role of this system in reproductive tissues. Components of the endocannabinoid system have been identified in myometrial and placental tissues. However, no study has investigated differential expression of the endocannabinoid system in labor.Objectives The purpose of this study was to identify and quantify two components of the endocannabinoid system, the CB1 cannabinoid receptor and cannabinoid receptor interacting protein 1a, in uterine and placental tissues, and to determine if there is differential expression in tissues exposed to labor. We hypothesized that CB1 cannabinoid receptor concentration would be altered in uterine and placental tissue exposed to labor as compared to tissues not exposed to labor.Study Design Uterine and placental tissue samples were collected in nine laboring and 11 non-laboring women undergoing cesarean delivery. CB1 cannabinoid receptor and cannabinoid receptor interacting protein 1a presence and quantification were evaluated using western blot and real-time quantitative polymerase chain reaction. Statistical comparisons of laboring and non-laboring subjects were made for uterine and placental tissue using a Mann-Whitney test.Results The protein abundance of CB1 cannabinoid receptor in uterine tissue was significantly lower in tissues exposed to labor (p = 0.01). The protein abundance of cannabinoid receptor interacting protein 1a was lower in uterine tissue exposed to labor but did not reach statistical significance (p = 0.06). mRNA expression of CB1 cannabinoid receptor (p = 0.20) and cannabinoid receptor interacting protein 1a (p = 0.63) did not differ in labored compared to non-labored uterine tissues.Conclusions Our findings of diminished protein density of CB1 cannabinoid receptor in uterine tissue exposed to labor support the hypothesis that the endocannabinoid system plays a role in parturition. Our data add to the growing body of evidence indicating the endocannabinoid system is of importance for successful reproduction and support the need for additional research investigating this complex system as it pertains to labor.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03752021Funding StatementThis work was supported by National Institute on Drug Abuse (NIDA) grant R01-DA042157 and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through grant UL1-TR001420. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval obtained from Wake Forest Baptist Medical Center - IRB000051905.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, [MLK], upon reasonable request.